8:00 am Check-in & Coffee
9:00 – 12:00 Assessing Current & Future Commercial Opportunities in Bringing Cell Therapies to the Autoimmune Space
9:00 am Workshop A
Synopsis
Owing to exciting advancements in the applications of cell therapies to autoimmune diseases developers are looking to grasp as many opportunities here as possible. However, with the vast amount of autoimmune indications, numerous cell therapy types, and other available therapy modalities, assessing which patients would benefit most from cell therapies and the feasibility of entering that space is crucial.
Join this workshop to:
• Explore the commercial landscape and opportunities of cell therapies in autoimmune diseases to understand areas of unmet need that are feasible to expand into
• Gain insights into key considerations when entering and expanding in this space including raising capital and market trends
• Evaluate the benefit-to-risk ratio when expanding into new areas and understand which indications benefit most from certain cell therapy types
• Discuss long-term considerations for developing cell therapies for autoimmune diseases such as patient access and reimbursement and the commercial pathway
12:00pm-1:00pm Lunch Break & Networking
1:00 – 4:00 Outlining Key Logistical Considerations for Successful Cell Therapy Trials for Autoimmune Patients
1:00 pm Workshop B
Synopsis
With many developers rapidly moving into clinics with candidates that have demonstrated outstanding preclinical results the community now faces challenges in maximizing clinical outcomes when facing competition for clinical resources in the oncology field and a lack of awareness of cell therapies in the autoimmune field.
Join this workshop to:
• Discover the essential logistical and technical strategies for increasing capacity for autoimmune trials such as staff training, clinical equipment, and trial investigator recruitment
• Troubleshoot pressing challenges in sharing resources in oncology clinics such as apheresis slots and in-patient capacity
• Discuss strategies to unite autoimmune specialities with oncologists to strengthen clinical understanding of cell therapies
• Explore how you can leverage partnerships with academic and clinical institutions to invest resources into increasing clinical capacity
• Assess techniques to manage the logistical complexities of running cell therapy autoimmune trials